Primary lymphedema

Genetic Causes of Three Previously Unexplained Rare Diseases Identified

Retrieved on: 
Thursday, March 16, 2023

NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Using a new computational approach they developed to analyze large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterized by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness. The work was done in collaboration with colleagues at the University of Bristol, UK; KU Leuven, Belgium; the University of Tokyo; the University of Maryland; Imperial College London, and others from around the world.

Key Points: 
  • Rare diseases affect approximately 1 in 20 people, but only a minority of patients receive a genetic diagnosis.
  • Genome sequencing of large cohorts of rare disease patients provides a route toward discovering the genetic causes that remain unknown.
  • The researchers identified 260 associations between genes and rare disease classes, including 19 associations previously absent from the literature.
  • "We also plan to apply our methods in novel ways and in other datasets, with the aim of continuing to unravel the genetic causes of rare diseases."

Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team

Retrieved on: 
Tuesday, December 27, 2022

OAKLAND, Calif., Dec. 27, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the addition of Dr. Thomas Maldonado as Chief Medical Officer. The addition of Dr. Maldonado further strengthens Koya Medical's clinical advisory board, led by Stanley Rockson, M.D., cardiologist and professor in the Falk Cardiovascular Research Center at Stanford University School of Medicine.

Key Points: 
  • OAKLAND, Calif., Dec. 27, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the addition of Dr. Thomas Maldonado as Chief Medical Officer.
  • The addition of Dr. Maldonado further strengthens Koya Medical's clinical advisory board, led by Stanley Rockson, M.D., cardiologist and professor in the Falk Cardiovascular Research Center at Stanford University School of Medicine.
  • has been one of New York City's top vascular surgeons in one of the nation's premier academic medical centers for over two decades.
  • He is regularly featured as Top Doctor by Castle Connolly and has served as president of numerous national and regional vascular societies.

Global Lymphedema Treatment Market Forecast (2021 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, February 28, 2022

The "Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Condition Type, Treatment Type, and End-User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Condition Type, Treatment Type, and End-User" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the lymphedema treatment market is attributed to the escalating incidence of secondary lymphedema, and the increasing number of healthcare services and lymphedema management programs.
  • Based on condition type, the global lymphedema treatment market has been segmented into primary lymphedema and secondary lymphedema.
  • Based on treatment type, the global lymphedema treatment market has been segmented into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others.